 | This article includes a list of general references, but it lacks sufficient corresponding inline citations. Please help to improve this article by introducing more precise citations. (April 2023) (Learn how and when to remove this message) |
Somnogen is a Canadian multinational pharmaceutical corporation with its global headquarters located in Toronto, Canada. Somnogen produces and develop a wide range of prescription and over-the-counter medications in the field of sleep medicine. Somnogen has a portfolio of products for major areas within the field of sleep/wake therapeutic segment including insomnia and excessive daytime sleepiness.
Somogen was founded by Seithikurippu Ratnas Pandi-Perumal, who was an Indian-born Canadian citizen. Somnogen initially launched its operation in India with a set of prescription and over-the-counter portfolio sleep medications. Currently the company doesn't have a factory of its own, but contract manufactures its products with othercompanies.
Product portfolio
Achoosom tablets (Diphenhydramine HCl 10 mg)
Benzax 0.25/0.5 mg tablets (Alprazolam 0.25 mg and 0.5 mg)
Benzax-F tablets (Alprazolam 0.25 mg + Fluoxetine 20 mg)
Depresom-ID tablets (Imipramine HCl 25 mg + Diazepam 5 mg)
Doxesom tablets (Doxepin HCl 3 mg)
Hydrozet-10 tablets (Cetirizine HCl 10 mg)
Loresta tablets (Lorazepam 1 mg and 2 mg)
Somnotril 0.5 tablets (Clonazepam 0.5 mg)
Somnolex tablets (Clonazepam 0.5 mg + Ecitalopram 10 mg)
Tophan capsules (Tryptophan 50 mg)
Xanfeine tablets (Caffeine 100 mg)
Zoltar 5/10 tablets (Zolpidem tartrate 5 mg and 10 mg)